Grants Dashboard

The Providers Clinical Support System (PCSS) will enhance the nation's capacity to respond to the ongoing opioid epidemic through innovative training, mentoring and implementation support to physicians and allied health professionals with the overarching goal to increase the availability of FDA approved medications for opioid use disorder (OUD). Continuing from and enhancing work from the current and previous funding cycles, specific goals of the PCSS are: (1) to increase the number of providers of evidence-based opioid treatment (and specifically buprenorphine waivered prescribers and delivery teams), (2) enhance competencies of allied health professionals, (3) build healthcare organization capacity to deliver OUD treatment and (4) improve providers ability to identify and impact structural barriers to successful OUD treatment. PCSS will continue to be led by the American Academy of Addiction Psychiatry (AAAP) and a committed consortium of partners representing interdisciplinary health professional in addiction psychiatry/medicine, primary care, implementation science, behavioral health, prevention and recovery, including all five DATA 2000 organizations. The consortium is enhanced in this application to include an expanded role of the Addiction Technology Transfer Center (ATTC), experts in training addiction behavioral health specialists and the Council on Social Work Education (CSWE), American Psychiatric Nurses Association (APNA) Physicians Assistant Education Association (PAEA) and the National Judicial College (NJC), reflecting broader reach to new prescriber and behavioral health provider groups and the justice system. In earlier funding cycles, PCSS developed a robust program of readily accessible web-based training tools for OUD treatment(e.g., webinars, list-serves, discussion boards, mentoring services)as well as in-person training curriculum for buprenorphine waiver training, to thousands of physicians, other prescribers and allied health professionals. In the most recent cycle, PCSS also developed and piloted a manualized implementation facilitation program for primary care programs to integrated OUD treatment. PCSS consortium now proposes to continue and expand these services to meet the following objectives: a) provide buprenorphine waiver training to over 11,000 physicians, nurse practitioners, physicians assistants and medical students; b) expand existing resources to include the addition of the PCSS Exchange, a flexible, continuous series of training and technical assistance for prescribers and allied health professionals; c) expand PCSS implementation into emergency departments and develop a curriculum to train implementation specialists; and d) enhance training content on poly-substance use, co-occurring mental health disorders, culturally intelligent practice and addressing social and economic barriers to successful OUD treatment. The opioid epidemic has compelled the healthcare system to re-evaluate methods for treating substance use disorders by offering a "no wrong door" approach; PCSS is committed to training the addiction workforce in diverse settings to provide patient-centered, appropriate, evidence-based care to help turn the tide of the opioid epidemic.